Black Diamond Therapeutics BDTX
NASDAQ BDTX
$1.88 -0.20 (-9.62%)
At close: Oct 23, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Gains from Investment Securities (2019 - 2025)

Updated

Analysis

Black Diamond Therapeutics (BDTX) Gains from Investment Securities (2019 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Black Diamond Therapeutics 108.71 Mn -384.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 71,000.00
Mar 31, 2021 1,000.00
Dec 31, 2020 24,000.00
Dec 31, 2019 23,000.00
Sep 30, 2019 -1.12 Mn
Jun 30, 2019 -5.30 Mn
API Access

Black Diamond Therapeutics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=BDTX&period=max&api_key=YOUR_API_KEY